Did you know that weight loss surgery can decrease the risk of some medical conditions in patients?
According to a recent New York Times article, a new study (conducted by the Cleveland Clinic) reveals that having weight loss surgery can actually decrease a patient’s overall risk of heart attacks, heart conditions and other cardiovascular diseases by almost 50 per cent.
“The new information here is the ability of bariatric surgery to control macrovascular events like strokes, heart attacks, heart failure and kidney disease, not just improve weight and diabetes control,” commented Dr. Edward H. Livingston, a bariatric surgeon, in his editorial article about the subject. “That’s a big deal.”
This study’s results were announced at the European Society of Cardiology Congress in Paris in September 2019.
Researchers chose over 2,000 Cleveland Clinic patients with obesity and Type 2 Diabetes and who had undergone a bariatric procedure to participate in the study. Most of the patients had had either a gastric bypass or gastric sleeve procedure, while a few others had the gastric band or duodenal switch.
The researchers then found over 11,000 other patients with obesity and diabetes to compare to the bariatric surgery patients specified above.
Findings from this study conclude that patients who had had a weight loss procedure were 41 per cent less likely to pass away of any cause; ten per cent of these patients passed during the study, whereas 17.8 per cent of patients who had not had the surgery passed from cardiovascular conditions.
“Patients who had [weight loss] surgery also lost an average of 15 per cent more weight than those who did not, and they had lower blood-sugar levels. They needed less medication to control diabetes and less insulin after the operation than the comparison group, and required fewer drugs to control blood pressure and cholesterol,” Rony Caryn Rabin, author of the New York Times article, states.
Dr. Ali Aminian, a surgeon and the study’s lead author, said the next project would be a controlled clinical trial that randomly assigns similar patients either to bariatric surgery or to regular health care, according to the article.